Clinical Trials Browser

Central Nervous System Neoplasms × mirdametinib × Clear all

NCT07539441 2026-04-20

A Study of Mirdametinib in People With Central Nervous System Tumors

Phase 1/2 Recruiting

Glioma, Central Nervous System Neoplasms